HTG MOLECULAR DIAGNOSTICS, INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2023.
  • Htg Molecular Diagnostics, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$1.31M, a 124% decline year-over-year.
  • Htg Molecular Diagnostics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $8.6M, a 17.2% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $10.4M, a 14.8% increase from 2020.
  • Htg Molecular Diagnostics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $9.05M, a 53.3% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$1.31M -$6.88M -124% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $5.57M -$962K -14.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $6.53M +$3.77M +136% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $2.76M +$3.23M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 -$466K -$39.3M -101% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q1 2018 $38.8M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.